Drugs Experience for Adolescents With Anorexia (E3P)

Assistance Publique - Hôpitaux de Paris

Status: Enrolling

Conditions: Psychotropic Drugs; Anorexia Nervosa; Adolescent

Treatments: Other: Semi-structured interviews with visual mediations; Other: Semi-structured interviews

Study type: Observational

Funder types: Other

Identifiers

NCT06211517

2022-A02141-42 (Other Identifier)

APHP230062

Details and patient eligibility

About

The purpose of this study is to access to the experiences of adolescents, their parents and healthcare professionals regarding psychotropic drugs in anorexia nervosa.

No preconceived ideas (according to qualitative methods) but a question: what are the participants' perceptions and experiences of psychotropic drugs in anorexia nervosa? In an adolescent medicine department.

Full description

Psychotropic prescription is common to adolescents suffering from anorexia nervosa. A first qualitative study (E3A Protocol "Experience of adolescents with anorexia nervosa toward antidepressants") looked at the experience of antidepressants among 15 adolescents suffering from anorexia nervosa. Analysis of the interviews identified two meta-themes:

1. Reactions to the proposal of antidepressant with an opposition phase (about the existence of depressive symptoms and about negative preconceptions) and need to share with family and other teenagers.
2. Reactions to antidepressant use with ambivalence and an initial perception of coercion, and effects of antidepressants (psychological effects, effects on the body and on anorexia nervosa and effects perceived through the eyes of others).

Nine adolescents (out of 15) were also taking an atypical antipsychotic (APA) often prescribed in case of anorexia nervosa resistance.

The need to share with family about the proposal of antidepressant and the effects perceived through the eyes of others (including parent's eyes) lead us to take an interest in parents perceptions.

Two decisive periods were identified: What do healthcare professionals think about psychotropic treatments for anorexia nervosa in adolescence? How do they propose treatment?

Interviewing teenagers, their parents as well as healthcare professionals, will enable to access to the complexity of representations and experiences of these psychotropic drugs in anorexia nervosa.

Enrollment: 90 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Adolescents :

• Aged 12 to 25 years
• Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria
• Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started

Parents of adolescents suffering from anorexia nervosa for whom a psychotropic drug has been prescribed and whose adolescents meet inclusion criteria

Healthcare Professionals working with adolescents suffering from eating disorders

Exclusion criteria

Adolescents :

• Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa
• BMI<15
• Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor)
• Prescription of an APA for the indication of psychotic symptoms

Trial design

90 participants in 3 patient groups

Adolescents

Description:

Adolescents suffering from anorexia nervosa 12 to 25 years

Treatment:

Other: Semi-structured interviews with visual mediations

Parents

Description:

Parents whose adolescents suffer from anorexia nervosa

Treatment:

Other: Semi-structured interviews with visual mediations

Healthcare professionals

Description:

Healthcare professionals in charge of adolescents suffering from anorexia nervosa

Treatment:

Other: Semi-structured interviews